Fluorescein versus Indocyanine Green Angiography Guided Half-Dose Photodynamic Therapy for Chronic Central Serous Chorioretinopathy

被引:1
作者
Moodi, Farzan [1 ,2 ]
Naseripour, Masood [1 ,2 ,3 ]
Zand, Amin [1 ,2 ]
Mirshahi, Reza [1 ,2 ]
Moodi, Vihan [4 ]
Alemzadeh, Sayyed Amirpooya [1 ,2 ]
Falavarjani, Khalil Ghasemi [1 ,2 ,3 ,5 ]
机构
[1] Iran Univ Med Sci, Senses Hlth Inst 5, Eye Res Ctr, Rassoul Akram Hosp,Sch Med, Tehran, Iran
[2] Iran Univ Med Sci, Senses Hlth Inst 5, Dept Ophthalmol, Rassoul Akram Hosp,Sch Med, Tehran, Iran
[3] Iran Univ Med Sci, Stem Cell & Regenerat Med Res Ctr, Tehran, Iran
[4] Univ Tehran Med Sci, Sch Med, Tehran, Iran
[5] Rassoul Akram Hosp, Eye Res Ctr, Sattarkhan Niaiesh St, Tehran 14456, Iran
关键词
Central Serous Chorioretinopathy; Fluorescein Angiography; Indocyanine Green Angiography; Photodynamic Therapy; VERTEPORFIN;
D O I
10.18502/jovr.v19i1.15420
中图分类号
R77 [眼科学];
学科分类号
100212 ;
摘要
Purpose: To compare the outcomes of fluorescein angiography (FA)-guided and indocyanine green angiography (ICGA)-guided half-dose photodynamic therapy (PDT) in patients with chronic central serous chorioretinopathy (CSC). Methods: In this retrospective comparative study, medical records of eyes with chronic CSC who underwent half-dose PDT were reviewed. A retina specialist performed FA-guided half-dose PDT, and the other performed ICGA-guided treatment. The success of applying PDT in the resolution of subretinal fluid was compared between the FA- and ICGA-guided methods. Results: Eighty-two eyes of 73 patients (41 eyes in each group) received half-dose PDT. After halfdose PDT, a significant improvement in the best-corrected visual acuity (BCVA) was found at the time of the last follow-up in both groups (both P < 0.001), with no significant intergroup difference. Central subfield and subfoveal choroidal thicknesses decreased significantly in both groups at the last follow-up (all P < 0.05), with no significant differences between the groups. Subretinal fluid (SRF) resolved in all eyes, and no persistent SRF was detected during the follow-up period. Conclusion: FA-guided and ICG-guided half-dose PDT may have similar efficacy for the treatment of chronic CSC.
引用
收藏
页码:12 / 17
页数:6
相关论文
共 21 条
[1]   Comparison of half-dose versus half-fluence versus standard photodynamic therapy in chronic central serous chorioretinopathy [J].
Altinel, Meltem Guzin ;
Kanra, Ayse Yagmur ;
Totuk, Ozgun Melike Gedar ;
Ardagil, Aylin ;
Kabadayi, Kerem .
PHOTODIAGNOSIS AND PHOTODYNAMIC THERAPY, 2021, 33
[2]   Safety enhanced photodynamic therapy for chronic central serous chorioretinopathy [J].
Chan, Wai-Man ;
Lai, Timothy Y. Y. ;
Lai, Ricky Y. K. ;
Tang, Emily W. H. ;
Liu, David T. L. ;
Lam, Dennis S. C. .
RETINA-THE JOURNAL OF RETINAL AND VITREOUS DISEASES, 2008, 28 (01) :85-93
[3]   Central serous chorioretinopathy: Recent findings and new physiopathology hypothesis [J].
Daruich, Alejandra ;
Matet, Alexandre ;
Dirani, Ali ;
Bousquet, Elodie ;
Zhao, Min ;
Farman, Nicolette ;
Jaisser, Frederic ;
Behar-Cohen, Francine .
PROGRESS IN RETINAL AND EYE RESEARCH, 2015, 48 :82-118
[4]   Comparison of the fluorescein angiography-guided and indocyanine green angiography-guided photodynamic therapy in the treatment of non-resolving central serous chorioretinopathy [J].
Ebrahimiadib, Nazanin ;
Mirzaei, Arash ;
Esfandiarifard, Shaghayegh ;
Tuli, Sonal ;
Najibzadeh, Ehsan ;
Fooladi, Marjan Imani ;
Fadakar, Kaveh .
SCIENTIFIC REPORTS, 2023, 13 (01)
[5]   Photodynamic therapy for central serous chorioretinopathy [J].
Erikitola, O. C. ;
Crosby-Nwaobi, R. ;
Lotery, A. J. ;
Sivaprasad, S. .
EYE, 2014, 28 (08) :944-957
[6]   One-Year Outcomes with Half-Dose Verteporfin Photodynamic Therapy for Chronic Central Serous Chorioretinopathy [J].
Fujita, Kyoko ;
Imamura, Yutaka ;
Shinoda, Kei ;
Matsumoto, Celso Soiti ;
Mizutani, Yoshihiro ;
Hashizume, Kouhei ;
Mizota, Atsushi ;
Yuzawa, Mitsuko .
OPHTHALMOLOGY, 2015, 122 (03) :555-561
[7]   Central serous chorioretinopathy: an update on pathogenesis and treatment [J].
Gemenetzi, M. ;
De Salvo, G. ;
Lotery, A. J. .
EYE, 2010, 24 (12) :1743-1756
[8]   Comparison between the outcomes of fluorescein angiography-guided and indocyanine green angiography-guided half-time photodynamic therapy for central serous chorioretinopathy [J].
Hayashida, Mayuka ;
Miki, Akiko ;
Honda, Shigeru ;
Nakamura, Makoto .
PHOTODIAGNOSIS AND PHOTODYNAMIC THERAPY, 2020, 31
[9]   Fluorescein angiography as a primary guide for reduced-fluence photodynamic therapy for the treatment of chronic central serous chorioretinopathy [J].
Koytak, Arif ;
Bayraktar, Havvanur ;
Ozdemir, Hakan .
INTERNATIONAL OPHTHALMOLOGY, 2020, 40 (07) :1807-1813
[10]   FLUORESCEIN ANGIOGRAPHY-GUIDED PHOTODYNAMIC THERAPY WITH HALF-DOSE VERTEPORFIN FOR CHRONIC CENTRAL SEROUS CHORIORETINOPATHY [J].
Koytak, Arif ;
Erol, Kazim ;
Coskun, Erol ;
Asik, Nihal ;
Ozturk, Hakan ;
Ozerturk, Yusuf .
RETINA-THE JOURNAL OF RETINAL AND VITREOUS DISEASES, 2010, 30 (10) :1698-1703